- Report
- October 2024
- 181 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- April 2023
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
The Cardiac Arrest Drug market is a subset of the Cardiovascular Drugs market, which includes drugs used to treat and prevent heart and blood vessel diseases. Cardiac Arrest Drugs are used to treat sudden cardiac arrest, a medical emergency in which the heart suddenly stops beating. These drugs are typically administered intravenously or intramuscularly and work by restoring the heart's normal rhythm. Common Cardiac Arrest Drugs include epinephrine, amiodarone, lidocaine, and magnesium sulfate.
The Cardiac Arrest Drug market is highly competitive, with many companies offering a variety of products. Major players in the market include Pfizer, Merck, Sanofi, Novartis, and GlaxoSmithKline. Other companies in the market include AstraZeneca, Bristol-Myers Squibb, and Boehringer Ingelheim. Show Less Read more